☆ 4.6 Meeting Abstract

CEACAM1 is an IL-2R-dependent biomarker in patients with multiple autoimmune-diseases undergoing low-dose IL-2 therapy

JOURNAL OF IMMUNOLOGY (2022)

Get Full Text
Add to Collection

Journal

JOURNAL OF IMMUNOLOGY
Volume 208, Issue 1, Pages -

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.208.Supp.160.14

Keywords

-

Categories

Immunology

Funding

  1. [R01AI131643]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.